About Kamyar Bagheri
I am a motivated researcher passionate about harnessing the immune system to fight cancer. My current work explores the therapeutic potential of stem cell-derived NK cells and CAR-NK therapies, with a vision to advance translational immuno-oncology. I enjoy building international collaborations and am always open to joint projects in cellular immunotherapy, cancer immunology, and hematologic cancers.
Intro Content
Harnessing the potential of CAR-NK cell therapy in gastrointestinal cancers: From bench to bedside
Gastrointestinal cancers are highly lethal and often refractory to nonspecific chemo‑radiotherapy. Engineered immunotherapies, notably CAR‑NK cells, offer targeted, safer, allogeneic treatment with innate CAR‑independent killing.
Recent Comments
Excellent Job!
A rigorous, translationally important study: the activation/rest model isolates permanent senescence distinct from exhaustion and reveals CSD‑dependent vulnerabilities—MYC‑linked senescence in BBζ versus adaptive responses in 28ζ—pointing to CSD‑guided engineering and senescence‑targeted strategies to improve CAR‑T durability.